Anti-CD20/CD3 Antibody (Mosunetuzumab)
Catalog No.
F2100
Anti-CD20/CD3 Antibody (Mosunetuzumab)
Featured Products
Mosunetuzumab is a bispecific antibody derived from genetic engineering technology. It is mainly composed of two different monoclonal antibody fragments and can bind to CD20 and CD3 molecules at the same time. Its mechanism is to activate the killing effect of T cells on B cells by connecting T cells (through CD3) and B cells (through CD20). Mosunetuzumab is mainly used to treat relapsed or refractory B-cell non-Hodgkin's lymphoma.
Dry ice
1905409-39-3
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BTCT4465A
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD20/CD3
Please avoid freeze-thaw cycles.